Clinical studies recruiting near Lenexa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT07717840 A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Phase 1 · ICON Early Phase Services, LLC · Novo Nordisk A/S · NCT07437079 Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · ICON Clinical Research: Lenexa · Shionogi · NCT07093580 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site US10066 · Astellas Pharma Global Development, Inc. · NCT02960022 Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
Phase 1 · Research Site · AstraZeneca · NCT07228364 A Study of LY4088044 in Healthy Participants
Phase 1 · ICON · Eli Lilly and Company · NCT07090785 Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Phase 1 · ICON, Clinical Research Phase I Unit · Basilea Pharmaceutica · NCT06733675 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · United Imaging Consultants · Pfizer · NCT06989437 Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Phase 3 · Site-025 · Biohaven Therapeutics Ltd. · NCT07661056 A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Phase 1/Phase 2 · Local Institution - 0001 · Bristol-Myers Squibb · NCT06481306 A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants
Phase 1 · Lenexa Clinic · Eli Lilly and Company · NCT07662798 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Kansas Institute of Medicine Cancer and Blood Center · SWOG Cancer Research Network · NCT03418961 Extension Study for the Port Delivery System With Ranibizumab (Portal)
Phase 3 · Retina Associates · Hoffmann-La Roche · NCT03683251 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Kansas Institute of Medicine Cancer and Blood Center · SWOG Cancer Research Network · NCT03723928 A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants
Phase 1 · Lenexa Clinic · Eli Lilly and Company · NCT07592572 Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without C
Phase 2/Phase 3 · Retina Associates - Lenexa /ID# 283004 · AbbVie · NCT07592273 First Time in Human Study of Long Acting VH4524184 Formulations
Phase 1 · GSK Investigational Site · ViiV Healthcare · NCT06310551 MAD Study of IA-14069
Phase 1 · ICON plc. · ILAb Co., Ltd. · NCT05533372 A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Cl
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06702449 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Overland Park Surgery Center · Stryker Instruments · NCT03072927 A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uteri
Phase 3 · Lenexa · Sumitomo Pharma Switzerland GmbH · NCT05862272 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B V
Phase 1 · Grifols Investigative Site · GigaGen, Inc. · NCT07024641 A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Phase 2 · Johnson County Clinical Trials · Pfizer · NCT07575932 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Phase 2/Phase 3 · Retina Associates, LLC · EyeBiotech Ltd. · NCT07496567 Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing
Phase 1 · Lenexa Research Unit · Novartis Pharmaceuticals · NCT07626281 A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Pr
Phase 1 · Johnson County Clin-Trials · International AIDS Vaccine Initiative · NCT07565090 A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult
Phase 3 · Retina Associates, LLC · Regeneron Pharmaceuticals · NCT06541704 A Study of IBI3032 in Healthy Participants
Phase 1 · ICON Clinical Research · Fortvita Biologics (USA)Inc. · NCT07120425 Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 3 · Johnson County Clintrials · Amgen · NCT07037459 Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Phase 2 · Kansas Institute of Medicine Cancer and Blood Center · Alliance for Clinical Trials in Oncology · NCT02523014

Look up another city

Look up another condition